09:00 AM EDT, 06/20/2025 (MT Newswires) -- Health care stocks were steady premarket Friday with the iShares Biotechnology ETF (IBB) up 0.7% and the Health Care Select Sector SPDR Fund (XLV) easing 0.02% lower recently.

Regeneron Pharmaceuticals ( REGN ) and Sanofi ( SNY ) said the US Food and Drug Administration approved Dupixent for the treatment of adult patients with bullous pemphigoid. Shares of Sanofi ( SNY ) and Regeneron Pharmaceuticals ( REGN ) were up more than 1% pre-bell.